Although clinical translation of these results requires further detailed research owing to the large gap between a mouse disease model and human disease, our results indicate that CD73-positive cells might provide a new strategy for treating and managing pulmonary fibrosis. The gene discussed is NT5E; the disease is pulmonary fibrosis.